封面
市場調查報告書
商品編碼
1738429

數位疫苗市場-全球產業規模、佔有率、趨勢、機會及預測,按設備類型、應用、地區及競爭情況細分,2020-2030 年

Digital Vaccine Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Device Type, By Application, By Region & Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球數位疫苗市場價值為 12.8 億美元,預計到 2030 年將達到 20.3 億美元,複合年成長率為 7.98%。數位疫苗代表了預防性醫療保健的突破,利用基於軟體的平台來調節神經認知和行為途徑以調節免疫反應。與傳統疫苗不同,這些數位解決方案使用智慧型手機、平板電腦和穿戴式裝置來提供針對傳染病、慢性病和精神健康狀況的非侵入性、客製化干涉措施。隨著數位醫療技術的發展和對個人化、可擴展預防方法的需求增加,這個市場正在獲得關注。不斷成長的全球醫療保健需求,加上向綜合、數據驅動的醫療服務的轉變,支持了市場的擴張。數位疫苗定位於數位治療和免疫接種的交叉點,正在透過創新、經濟高效的預防保健解決方案重塑未來的公共衛生策略。

市場概覽
預測期 2026-2030
2024年市場規模 12.8億美元
2030年市場規模 20.3億美元
2025-2030 年複合年成長率 7.98%
成長最快的領域 智慧型手機
最大的市場 北美洲

關鍵市場促進因素

傳染病和慢性病發生率上升

主要市場挑戰

監管不確定性和複雜的核准流程

主要市場趨勢

數位疫苗與更廣泛的數位治療生態系統的整合

目錄

第 1 章:產品概述

第2章:研究方法

第3章:執行摘要

第4章:顧客之聲

第5章:數位疫苗市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依裝置類型(智慧型手機、平板電腦、其他)
    • 依應用(糖尿病、傳染病、心血管疾病、其他)
    • 按地區
    • 按公司分類(2024)
  • 市場地圖

第6章:北美數位疫苗市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美:國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章:歐洲數位疫苗市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲:國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第8章:亞太數字疫苗市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區:國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章:南美數位疫苗市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲:國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章:中東和非洲數位疫苗市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA:國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章:市場動態

  • 驅動程式
  • 挑戰

第 12 章:市場趨勢與發展

  • 最新動態
  • 產品發布
  • 併購

第 13 章:全球數位疫苗市場:SWOT 分析

第 14 章:競爭格局

  • Pfizer Inc.
  • Moderna, Inc
  • AstraZeneca Plc
  • Johnson & Johnson Service Inc.
  • Sanofi
  • GSK Plc.
  • Novavax
  • BioNTech SE
  • Bharat Biotech Ltd
  • Klein Buendel, Inc

第 15 章:策略建議

簡介目錄
Product Code: 12817

The Global Digital Vaccine Market was valued at USD 1.28 Billion in 2024 and is projected to reach USD 2.03 Billion by 2030, growing at a CAGR of 7.98%. Digital vaccines represent a breakthrough in preventive healthcare, utilizing software-based platforms to engage neurocognitive and behavioral pathways for modulating immune responses. Unlike conventional vaccines, these digital solutions employ smartphones, tablets, and wearable devices to deliver non-invasive, customized interventions targeting infectious diseases, chronic illnesses, and mental health conditions. This market is gaining traction as digital health technologies evolve and the demand for personalized, scalable prevention methods rises. Increasing global healthcare needs, coupled with the shift towards integrated, data-driven care delivery, support the market's expansion. Positioned at the intersection of digital therapeutics and immunization, digital vaccines are reshaping future public health strategies through innovative, cost-effective preventive care solutions.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.28 Billion
Market Size 2030USD 2.03 Billion
CAGR 2025-20307.98%
Fastest Growing SegmentSmartphones
Largest MarketNorth America

Key Market Drivers

Rising Incidence of Infectious and Chronic Diseases

The growing prevalence of infectious and chronic diseases is a primary catalyst propelling the Global Digital Vaccine Market. In 2021, non-communicable diseases accounted for over 43 million deaths, with 18 million classified as premature. These statistics are particularly concerning in low- and middle-income countries, where 82% of early deaths occurred. Concurrently, communicable diseases like tuberculosis, COVID-19, and influenza continue to impact global health, with TB alone causing 1.25 million deaths in 2023. The escalating burden on healthcare systems underscores the urgent need for preventive, scalable solutions. Digital vaccines offer timely, personalized interventions using software to manage and mitigate disease progression, thereby addressing a critical gap in traditional healthcare infrastructure.

Key Market Challenges

Regulatory Uncertainty and Complex Approval Processes

The absence of clear regulatory standards tailored for digital vaccines presents a considerable challenge for market growth. These software-based interventions straddle multiple domains-therapeutics, digital health, and preventive care-leading to ambiguity in classification and compliance. Regulatory bodies around the world differ in their evaluation and approval processes, which results in delays, inconsistent requirements, and elevated development costs. These factors deter investment, complicate commercialization, and hinder broader market adoption, especially in emerging regions.

Key Market Trends

Integration of Digital Vaccines with Broader Digital Therapeutics Ecosystems

A notable trend in the market is the merging of digital vaccines into comprehensive digital therapeutic ecosystems. Instead of operating as isolated tools, digital vaccines are increasingly becoming components of integrated health platforms that include AI diagnostics, remote monitoring, and personalized treatment. This ecosystem-based approach enhances clinical effectiveness through real-time analytics and interconnected care pathways. By fostering interoperability and cross-platform functionality, companies that prioritize ecosystem integration are poised to drive adoption and deliver greater value in preventive health.

Key Market Players

  • Pfizer Inc.
  • Moderna, Inc
  • AstraZeneca Plc
  • Johnson & Johnson Service Inc.
  • Sanofi
  • GSK Plc.
  • Novavax
  • BioNTech SE
  • Bharat Biotech Ltd
  • Klein Buendel, Inc

Report Scope:

In this report, the Global Digital Vaccine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Digital Vaccine Market, By Device Type:

  • Smartphones
  • Tablets
  • Others

Digital Vaccine Market, By Application:

  • Diabetes
  • Infectious Diseases
  • Cardiovascular Diseases
  • Others

Digital Vaccine Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Digital Vaccine Market.

Available Customizations:

Global Digital Vaccine market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Digital Vaccine Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Device Type (Smartphones, Tablets, Others)
    • 5.2.2. By Application (Diabetes, Infectious Diseases, Cardiovascular Diseases, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Digital Vaccine Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Device Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Digital Vaccine Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Device Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Digital Vaccine Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Device Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Digital Vaccine Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Device Type
        • 6.3.3.2.2. By Application

7. Europe Digital Vaccine Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Device Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Digital Vaccine Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Device Type
        • 7.3.1.2.2. By Application
    • 7.3.2. United Kingdom Digital Vaccine Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Device Type
        • 7.3.2.2.2. By Application
    • 7.3.3. Italy Digital Vaccine Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Device Type
        • 7.3.3.2.2. By Application
    • 7.3.4. France Digital Vaccine Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Device Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Digital Vaccine Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Device Type
        • 7.3.5.2.2. By Application

8. Asia-Pacific Digital Vaccine Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Device Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Digital Vaccine Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Device Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Digital Vaccine Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Device Type
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Digital Vaccine Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Device Type
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Digital Vaccine Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Device Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Digital Vaccine Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Device Type
        • 8.3.5.2.2. By Application

9. South America Digital Vaccine Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Device Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Digital Vaccine Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Device Type
        • 9.3.1.2.2. By Application
    • 9.3.2. Argentina Digital Vaccine Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Device Type
        • 9.3.2.2.2. By Application
    • 9.3.3. Colombia Digital Vaccine Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Device Type
        • 9.3.3.2.2. By Application

10. Middle East and Africa Digital Vaccine Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Device Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Digital Vaccine Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Device Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Saudi Arabia Digital Vaccine Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Device Type
        • 10.3.2.2.2. By Application
    • 10.3.3. UAE Digital Vaccine Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Device Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Digital Vaccine Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Pfizer Inc.
    • 14.1.1. Business Overview
    • 14.1.2. Product & Service Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Financials (If Listed)
    • 14.1.5. Key Personnel
    • 14.1.6. SWOT Analysis
  • 14.2. Moderna, Inc
  • 14.3. AstraZeneca Plc
  • 14.4. Johnson & Johnson Service Inc.
  • 14.5. Sanofi
  • 14.6. GSK Plc.
  • 14.7. Novavax
  • 14.8. BioNTech SE
  • 14.9. Bharat Biotech Ltd
  • 14.10.Klein Buendel, Inc

15. Strategic Recommendations